Mark Tann

2.6k total citations
66 papers, 1.9k citations indexed

About

Mark Tann is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Hepatology. According to data from OpenAlex, Mark Tann has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 24 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Hepatology. Recurrent topics in Mark Tann's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Medical Imaging Techniques and Applications (11 papers) and Prostate Cancer Treatment and Research (10 papers). Mark Tann is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Medical Imaging Techniques and Applications (11 papers) and Prostate Cancer Treatment and Research (10 papers). Mark Tann collaborates with scholars based in United States, China and Israel. Mark Tann's co-authors include Kumaresan Sandrasegaran, Fatih Akisik, Temel Tirkes, S. Gregory Jennings, Helen T. Winer-Muram, Marc Kohli, James Fletcher, Robert Timmerman, Ronald C. McGarry and D.J. Hoopes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Mark Tann

66 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Tann United States 21 857 798 560 525 267 66 1.9k
Antonio C. Westphalen United States 29 1.9k 2.2× 1.1k 1.4× 692 1.2× 183 0.3× 201 0.8× 118 3.0k
Zahra Kassam Canada 20 812 0.9× 531 0.7× 596 1.1× 391 0.7× 553 2.1× 88 2.0k
Enrique Lopez Hänninen Germany 22 858 1.0× 404 0.5× 781 1.4× 540 1.0× 446 1.7× 43 1.8k
Shoichi Kusano Japan 23 1.1k 1.3× 813 1.0× 631 1.1× 299 0.6× 301 1.1× 119 2.3k
Venkatesh Rangarajan India 23 1.2k 1.4× 805 1.0× 710 1.3× 605 1.2× 74 0.3× 246 2.6k
Chiara Floridi Italy 26 710 0.8× 587 0.7× 565 1.0× 265 0.5× 249 0.9× 90 1.8k
Andrea Veltri Italy 29 1.2k 1.4× 767 1.0× 750 1.3× 416 0.8× 778 2.9× 136 3.0k
Christoph Trumm Germany 22 501 0.6× 329 0.4× 632 1.1× 344 0.7× 378 1.4× 89 1.6k
Nima Kokabi United States 22 575 0.7× 413 0.5× 537 1.0× 221 0.4× 614 2.3× 135 1.4k
Smith Apisarnthanarax United States 23 582 0.7× 372 0.5× 311 0.6× 412 0.8× 383 1.4× 93 1.5k

Countries citing papers authored by Mark Tann

Since Specialization
Citations

This map shows the geographic impact of Mark Tann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tann more than expected).

Fields of papers citing papers by Mark Tann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tann. The network helps show where Mark Tann may publish in the future.

Co-authorship network of co-authors of Mark Tann

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tann. A scholar is included among the top collaborators of Mark Tann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tann. Mark Tann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gawrieh, Samer, Jordan E. Lake, Mark Tann, et al.. (2023). Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study. Hepatology. 78(2). 578–591. 20 indexed citations
2.
Garin, Étienne, Xavier Palard-Novello, Armeen Mahvash, et al.. (2023). Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 51(1). 245–257. 4 indexed citations
3.
Gawrieh, Samer, Kathleen E. Corey, Jordan E. Lake, et al.. (2023). Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus. PLoS ONE. 18(2). e0279685–e0279685. 3 indexed citations
4.
Bahler, Clinton D., Mark A. Green, Mark Tann, et al.. (2022). Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care. Urologic Oncology Seminars and Original Investigations. 41(1). 48.e1–48.e9. 9 indexed citations
5.
Patel, Milan, Mark Tann, & Suthat Liangpunsakul. (2020). CT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis. The American Journal of the Medical Sciences. 362(3). 252–259. 10 indexed citations
6.
7.
Tann, Mark, et al.. (2018). Functional liver image guided hepatic therapy (FLIGHT) with hepatobiliary iminodiacetic acid (HIDA) scans. Practical Radiation Oncology. 8(6). 429–436. 9 indexed citations
8.
Sandrasegaran, Kumar, et al.. (2018). Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?. European Radiology. 28(10). 4215–4224. 13 indexed citations
9.
Suvannasankha, Attaya, Rafat Abonour, Sherif S. Farag, et al.. (2017). Phase 2 Study of Carfilzomib and Bone Metabolism in Patients with Relapsed Multiple Myeloma. Blood. 130. 1826–1826. 4 indexed citations
10.
Tirkes, Temel, et al.. (2016). Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma. PMC. 1 indexed citations
11.
Tirkes, Temel, et al.. (2016). Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma. Clinical and Molecular Hepatology. 22(4). 450–457. 8 indexed citations
12.
Green, Mark A., James Fletcher, Carla J. Mathias, et al.. (2016). Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer. Nuclear Medicine and Biology. 46. 32–35. 20 indexed citations
13.
Debiane, Labib, et al.. (2015). Utility of Lumbar Central Sarcopenia in Predicting Early Functional Status Following Lung Transplantation. CHEST Journal. 148(4). 1083A–1083A. 1 indexed citations
14.
Liu, Yubao, Fatih Akisik, Temel Tirkes, et al.. (2015). Value of magnetic resonance imaging in evaluating the pancreatic allograft transplant complications. Abdominal Imaging. 40(7). 2384–2390. 5 indexed citations
15.
Sandrasegaran, Kumar, Marwan Ghabril, Saurabh Agarwal, et al.. (2015). The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma. Digestive Diseases and Sciences. 60(7). 2196–2200. 5 indexed citations
16.
Monn, M. Francesca, Paul T. Gellhaus, Aashish Patel, et al.. (2014). Can Radiologists and Urologists Reliably Determine Renal Mass Histology Using Standard Preoperative Computed Tomography Imaging?. Journal of Endourology. 29(4). 391–396. 2 indexed citations
17.
Sandrasegaran, Kumaresan, Gregory A. Coté, Bilal Tahir, et al.. (2014). The utility of secretin-enhanced MRCP in diagnosing congenital anomalies. Abdominal Imaging. 39(5). 979–987. 11 indexed citations
19.
Tirkes, Temel, Kumaresan Sandrasegaran, Aashish Patel, et al.. (2012). Peritoneal and Retroperitoneal Anatomy and Its Relevance for Cross-Sectional Imaging. Radiographics. 32(2). 437–451. 102 indexed citations
20.
Winer-Muram, Helen T., et al.. (2004). Computed Tomography Demonstration of Lipomatous Metaplasia of the Left Ventricle Following Myocardial Infarction. Journal of Computer Assisted Tomography. 28(4). 455–458. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026